AAFA’s Allergy Capitals report reveals that people with seasonal pollen allergies in many parts of the U.S. may find managing their symptoms more challenging,” said Sanaz Eftekhari, AAFA’s vice ...

Does mouth taping help with snoring? Learn what the research says, potential risks, and safer, proven treatments that can ...

That was based on the phase III LIBERTY-AFRS-AIMS trial findings from 62 adults and kids with allergic fungal rhinosinusitis ...

The approval of depemokinab, of which Exdensur is the brand name, for chronic rhinosinusitis in addition to intranasal corticosteroids by China's National Medical Products Administration follows an ...

Lunsekimig, a bispecific drug aimed at two popular targets, succeeded in studies in asthma and nasal polyps but missed its mark in an eczema trial.

Sanofi has faced questions about the potential of lunsekimig in eczema, with executives calling the clinical trial a “measured risk.” ...

Sanofi SA SNY on Tuesday reported Phase 2 data for its experimental therapy lunsekimig in chronic respiratory diseases, ...

Sanofi’s TSLP and IL-13 inhibitor has aced a pair of mid-stage studies for respiratory diseases, but missed on a phase 2 ...

During the March 31 episode of Maria Menounos’ “Heal Squad” podcast, the former Playboy model revealed she was diagnosed with ...

You need to be aware of seasonal allergies, which can lead to Anaphylaxis, asthma and other serious health conditions.